Synthesis of Tc-99m labeled 1,2,3-triazole-4-yl c-met binding peptide as a potential c-met receptor kinase positive tumor imaging agent

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 14, 2010, Pages 4240-4243

  Kim, Eun Mi ^a   Joung, Min Hee ^a   Lee, Chang Moon ^a   Jeong, Hwan Jeong ^a   Lim, Seok Tae ^a   Sohn, Myung Hee ^a   Kim, Dong Wook ^a  

^a Chonbuk National University Medical School   (South Korea)

Author keywords

c Met; c Met binding peptide; Click chemistry; Technetium 99m

Indexed keywords

1,2,3 TRIAZOLE 4 YL C MET BINDING PEPTIDE TC 99 M; RADIOPHARMACEUTICAL AGENT; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL TRANSPORT; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; SOLID PHASE SYNTHESIS;

HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR PROTEIN-TYROSINE KINASES; TECHNETIUM; TRIAZOLES;

EID: 77953869488     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.05.036     Document Type: Article

References (22)

1. Gherardi E., and Stoker M. Nature 346 (1990) 228
2. Grant D.S., Kleinman H.K., Goldberg I.D., Bhargava M.M., Nickoloff B.J., Kinsella J.L., Polverini P., and Rosen E.M. Proc. Natl. Acad. Sci. 90 (1993) 1937
3. Ding S., Merkulova-Rainon T., Han Z.C., and Tobelem G. Blood 101 (2003) 4816
4. Karamouzis M.V., Konstantinopoulos P.A., and Papavassiliou A.G. Lancet Oncol. 10 (2009) 709
5. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., and Vande Woude G.F. Nature 311 (1984) 29
6. Date K., Matsumoto K., Shimura H., Tanaka M., and Nakamura T. FEBS Lett. 420 (1997) 1
7. Burgess T., Coxon A., Meyer S., Sun J., Rex K., Tsuruda T., Chen Q., Ho S.Y., Li L., Kaufman S., McDorman K., Cattley R.C., Sun J., Elliott G., Zhang K., Feng X., Jia X.C., Green L., Radinsky R., and Kendall R. Cancer Res. 66 (2006) 1721
8. Berthou S., Aebersold D.M., Schmidt L.S., Stroka D., Heigl C., Streit B., Stalder D., Gruber G., Liang C., Howlett A.R., Candinas D., Greiner R.H., Lipson K.E., and Zimmer Y. Oncogene 23 (2004) 5387
9. Ma P.C., Schaefer E., Christensen J.G., and Salgia R. Clin. Cancer Res. 11 (2005) 2312
10. Kim K., Hur Y., Ryu E.K., Rhim J.H., Choi C.Y., Baek C.M., Lee J.H., and Chung J. Biochem. Biophys. Res. Commun. 354 (2007) 115
11. Kim E.M., Park E.H., Cheong S.J., Lee C.M., Kim D.W., Jeong H.J., Lim S.T., Sohn M.H., Kim K., and Chung J. Nucl. Med. Biol. 36 (2009) 371
12. Kim E.M., Park E.H., Cheong S.J., Lee C.M., Jeong H.J., Kim D.W., Lim S.T., and Sohn M.H. Bioconjug. Chem. 20 (2009) 1299
13. Kolb H.C., Finn M.G., and Sharpless K.B. Angew. Chem., Int. Ed. 40 (2006) 2004
14. Rostovtsev V.V., Green L.G., Fokin V.V., and Sharpless K.B. Angew. Chem., Int. Ed. 41 (2002) 2596
15. Kolb H.C., and Sharpless K.B. Drug Discovery Today 8 (2003) 1128
16. Mindt T.L., Struthers H., Brans L., Anguelov T., Schweinsberg C., Maes V., Tourwé D., and Schibli R. J. Am. Chem. Soc. 128 (2006) 15096
17. Mindt T.L., Schweinsberg C., Brans L., Hagenbach A., Abram U., Tourwé D., Garcia-Garayoa E., and Schibli R. ChemMedChem 4 (2009) 529
18. Struthers H., Spingler B., Mindt T.L., and Schibli R. Chemistry 14 (2008) 6173
19. Schwochau K. Angew. Chem., Int. Ed. Engl. 33 (1994) 2258
20. Jurisson S., Berning D., Jia W., and Ma D. Chem. Rev. 93 (1993) 1137
21. Schibli R., Schwarzbach R., Alberto R., Ortner K., Schmalle H., Dumas C., Egli A., and Schubiger P.A. Bioconjug. Chem. 13 (2002) 750
22. Alberto R., Schibli R., Schubiger A.P., Abram U., Pietzsch H.-P., and Johannsen B. J. Am. Chem. Soc. 121 (1999) 6076